GFP
ELV icon

Gryphon Financial Partners’s Elevance Health ELV Stock Holding History

Gryphon Financial Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Buy
1,119
+120
+12% +$44.5K 0.04% 257
2026
Q1 		$293K Sell
999
-82
-8% -$26.9K 0.03% 291
2025
Q4 		$379K Buy
1,081
+75
+7% +$25.3K 0.04% 236
2025
Q3 		$325K Sell
1,006
-135
-12% -$42K 0.04% 251
2025
Q2 		$444K Buy
1,141
+24
+2% +$9.65K 0.06% 197
2025
Q1 		$486K Buy
1,117
+48
+4% +$19.3K 0.07% 172
2024
Q4 		$394K Sell
1,069
-181
-14% -$75.7K 0.06% 178
2024
Q3 		$650K Sell
1,250
-18
-1% -$9.62K 0.09% 141
2024
Q2 		$687K Buy
1,268
+72
+6% +$38.1K 0.1% 122
2024
Q1 		$620K Buy
+1,196
New +$595K 0.1% 132
2023
Q4 		– Sell
-909
Closed -$396K – 241
2023
Q3 		$396K Buy
909
+508
+127% +$230K 0.09% 114
2023
Q2 		$178K Sell
401
-510
-56% -$235K 0.04% 192
2023
Q1 		$419K Sell
911
-70
-7% -$33.3K 0.1% 117
2022
Q4 		$503K Sell
981
-165
-14% -$83.8K 0.12% 98
2022
Q3 		$521K Sell
1,146
-59
-5% -$28.2K 0.13% 90
2022
Q2 		$582K Sell
1,205
-393
-25% -$194K 0.14% 84
2022
Q1 		$785K Buy
1,598
+25
+2% +$11.4K 0.16% 75
2021
Q4 		$729K Sell
1,573
-202
-11% -$85K 0.14% 92
2021
Q3 		$662K Buy
1,775
+150
+9% +$57K 0.15% 85
2021
Q2 		$461K Buy
1,625
+111
+7% +$42.4K 0.1% 103
2021
Q1 		$543K Buy
1,514
+10
+0.7% +$3.22K 0.12% 86
2020
Q4 		$483K Sell
1,504
-73
-5% -$22.4K 0.12% 94
2020
Q3 		$423K Buy
1,577
+271
+21% +$72.9K 0.13% 97
2020
Q2 		$343K Buy
+1,306
New +$348K 0.11% 98
2018
Q3 		– Sell
-146
Closed -$35K – 359
2018
Q2 		$35K Sell
146
-2
-1% -$463 0.02% 282
2018
Q1 		$33K Sell
148
-39
-21% -$9.16K 0.02% 294
2017
Q4 		$42K Buy
+187
New +$39.8K 0.02% 275

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Gryphon Financial Partners's ELV Position: Q2 2026 in Review

Gryphon Financial Partners increased its Elevance Health (ELV) stake by 12% in Q2 2026, buying an estimated $44.5K and bringing the position to 1,119 shares worth $433K. The position accounts for 0.04% of the portfolio, ranked #257.

Gryphon Financial Partners first reported a position in ELV in Q4 2017 and has held it in 27 quarters since. The position peaked at $785K in Q1 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Gryphon Financial Partners held 1,119 shares of Elevance Health worth $433K as of Q2 2026.
  • Gryphon Financial Partners bought 120 Elevance Health shares in Q2 2026, an estimated $44.5K.
  • Elevance Health made up 0.04% of Gryphon Financial Partners's portfolio in Q2 2026, its #257 holding.
  • Gryphon Financial Partners first reported a position in Elevance Health in Q4 2017 and has held it in 27 quarters since.
  • Gryphon Financial Partners's Elevance Health position peaked at $785K in Q1 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.